Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
نویسندگان
چکیده
منابع مشابه
Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
BACKGROUND Previous studies have suggested a greater benefit for various outcomes in men diagnosed with benign prostatic hyperplasia (BPH) who are treated with dutasteride than for men treated with finasteride. This study investigates whether the rates of BPH-related prostate surgery and acute urinary retention (AUR) differ between dutasteride and finasteride users in the Netherlands. METHODS...
متن کاملEffect of dutasteride on microvessel density in benign prostatic hyperplasia.
AIM Dutasteride, a dual 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH). However, its histopathological effects on the morphometrics of blood vessels and glands are still controversial. This study aimed to assess the histopathological effects of dutasteride in cases of BPH in a retrospective manner. PATIENTS AND METHODS Patients with BPH were administered 0.5 mg of...
متن کاملDutasteride Is Effective for Patients with Benign Prostatic Hyperplasia in Hemodialysis
Hypothesis / aims of study Among dialysis patients urine production is kept, complaining of lower urinary tract symptoms (LUTS) are observed, some were reported underwent surgery for benign prostatic hyperplasia (BPH). However, there are many patients with complications having difficulty in surgery , it is often managed by a placement of catheter. Dutasteride (DUT) reduces prostate volume and i...
متن کاملMarked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
Dihydrotestosterone (DHT) is the primary metabolite of testosterone in the prostate and skin. Testosterone is converted to DHT by 5alpha-reductase, which exists in two isoenzyme forms (types 1 and 2). DHT is associated with development of benign prostatic hyperplasia (BPH), and reduction in its level with 5alpha-reductase inhibitors improves the symptoms associated with BPH and reduces the risk...
متن کاملSerum Biochemical and Hematological Parameters in Dogs with Benign Prostatic Hyperplasia (BPH)
BACKGROUND: Clinical prostatic diseases occur in 80% of dogs over 5 and 95% over 9 years of age. . It seems that benign prostatic hyperplasia) BPH) affect Scottish terriers more severely than the other breeds. OBJECTIVES: This study aimed to evaluate the changes of biochemical and hematological parameters in BPH dogs. METHODS: Blood samples were collected from 10 male dogs older than five year...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Drug Investigation
سال: 2018
ISSN: 1173-2563,1179-1918
DOI: 10.1007/s40261-018-0733-2